Skip to main content
Clinical Trials/NCT05166642
NCT05166642
Suspended
Not Applicable

Prospective, Randomized Clinical Trial Assessing Post-operative Wound Healing Complications Following Total Joint Arthroplasty When Using Bandgrip Incision Closure Compared to Standard Suture Closure

Center for Innovation and Research Organization1 site in 1 country100 target enrollmentMarch 8, 2021
ConditionsOsteoarthritis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Center for Innovation and Research Organization
Enrollment
100
Locations
1
Primary Endpoint
Number of patients with wound healing complications
Status
Suspended
Last Updated
2 years ago

Overview

Brief Summary

Total Joint Arthroplasty (TJA) has become one of the most performed elective procedures. While the results of this procedure are often consistent with high patient satisfaction and return-to-function, wound-related complications can contribute to high-cost "bundle busters". Following surgery, wound drainage or other wound complications can lead to increased cost and decreased patient satisfaction. Secure wound closure is an important step in preventing wound-related complications. The surgical incision should be closed in a manner that prevents the wound edges from separating which could lead to possible drainage and bacterial contamination of the incision.

Traditional incision closure following TJA includes sutures. These sutures are then removed in the office. BandGrip is a wound closure device that can be used to approximate skin edges of wounds from surgical incisions and traumatic lacerations. It is a bandage-type patch with several small skin anchors that are used to hold the skin edges together. The clear microanchors are 0.029 inches in height and do not puncture through the dermis. There is no need for medical removal as the patient can remove the bandage.

Registry
clinicaltrials.gov
Start Date
March 8, 2021
End Date
January 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Center for Innovation and Research Organization
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject is male or female greater than 18 years of age
  • Scheduled to undergo primary total knee or total hip replacement
  • Able to read and comprehend informed consent form and comply with the follow-up evaluation schedule

Exclusion Criteria

  • Prior surgical incision or scar in close proximity of the proposed incision (\<2 cm).
  • Local skin conditions such as dermatitis, eczema, or psoriasis.
  • Active or previous infection in the skin or the hip or knee to be operated.
  • Inflammatory arthritis; connective tissue or vascular disorders or diseases that would adversely affect wound healing including the use of oral or topical corticosteroid use
  • Subject has a recent history of bleeding, coagulation and/or clotting disorders
  • Subject has a known allergy to BandGrip material (polycarbonate)

Outcomes

Primary Outcomes

Number of patients with wound healing complications

Time Frame: From time of surgery to 30 days post-op

All wound-related complication following surgery

Secondary Outcomes

  • Closure time of surgical wound(Procedure (The time from the first skin pass with the suture needle until the time the last suture knot is tied will be recorded in seconds))

Study Sites (1)

Loading locations...

Similar Trials